Wall Street limits losses

U.S. stock markets have taken the path of lower end of the session after some hesitation on the way to go Wednesday. The Dow Jones finally folds of 0.23% at 10,833 points, the Standard & Poor's 500 by 0.26% to 1145 points and the Nasdaq 100 0.13% to 2377 points. After spending the day near the equilibrium point, the indices of the Wall Street nose dive in the last hour of trade.

"The month of September is very good so far," observed Art Hogan of Jefferies. "We now have important catalysts to continue to rise.We had none today (Wednesday), and some sources of concern, it is understandable that we take stock of the value of shares and take out money from the table " .

Tuesday, after long hesitation which direction to take, the U.S. stock market finally closed higher.

On the foreign exchange market, the euro climbed further against the dollar. One euro is trading over $ 1.36 cons. The greenback continues to suffer from renewed speculation of further monetary easing in the U.S. after a new series of disappointing indicators.

On the macroeconomic front, the U.S., investors have followed including the number of weekly inventory of crude oil, which reflected a decrease of 475,000 barrels on al week ended Sept. 24, against 300,000 expected by analysts.

A redemption for Endo Pharmaceuticals

The side of values, the news of mergers and acquisitions is provided. Endo Pharmaceuticals (-1.51% to 32.6 dollars) announced it would buy Qualitest Pharmaceutial, unlisted, for about $ 1.2 billion.

For its part Apple (+0.18% to 287.37 dollars) should respond to new rumors of departure from the group's number two Hewlett-Packard.

Always on the side of values, Sanofi-Aventis (-0.39% to 33.6 dollars) could increase its takeover offer for the American Genzyme 1 to $ 2 next week, according to Bloomberg. Currently the French group offers $ 69 per share Genzyme. The Financial Times suggests in turn a possible resignation of the head of the U.S. biotech by next summer.The latter said that his group would discuss with no white knight.

On its side Caterpillar (+0.35% to 79.95 dollars) has announced the construction of a new assembly plant in China. It will produce small gear hydraulic excavation, from 2012 to the Chinese market.

Also note, Toy's "R" Us has announced anticipate hiring additional staff of 45,000 by the end of the year with a doubling of its workforce in the United States. This announcement highlights a group optimistic on sales year-end.

Procter & Gamble is interested in Nivea. The rumors are back. Nivea is "a fantastic brand," says the boss of U.S. giant Procter & Gamble (-0.63% to 60.24 dollars), Robert McDonald.